Replies to post #226445 on Biotech Values

[dewophile]

DD and I had a brief back and forth about this recently where we had a bit of a disagreement on the significance of HBSAg reductions

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151516620

[DewDiligence]

ASMB—You’re reading the PR correctly, IMO.

How strong is the evidence that the [CpAM + nuke] combo will ultimately lead to a functional cure?

For the first-generation drug (ABI-H0731), I'd say the evidence, such as it is, points in the opposite direction. For the second-generation drug (ABI-H2158), it’s too soon to say.

p.s. See #msg-148672065.